aspect of
drug)
→
ReceivesAction
→
discussed in greater detail
| Typicality: | 0.300 |
| Saliency: | 0.118 |
| effect → be discussed in → greater detail | 3 |
| effect → be discussed in → detail | 3 |
| negative | neutral | positive |
| 0.232 | 0.742 | 0.026 |
| Raw frequency | 6 |
| Normalized frequency | 0.118 |
| Modifier score | 0.500 |
| Perplexity | 31.291 |